Verdezyne
closedIndustrial biotechnology company directing the power of biology to create bio-based processes for clean and sustainable chemicals.
Launch date
Employees
Market cap
-
Enterprise valuation
€175—262m (Dealroom.co estimates Mar 2015.)
Carlsbad California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$750k | Series A | ||
N/A | N/A | Seed | |
$1.6m | Early VC | ||
$7.0m | Series C | ||
N/A | N/A | Seed | |
$3.0m | Early VC | ||
N/A | N/A | Seed | |
$9.0m | - | ||
N/A | Early VC | ||
N/A | N/A | Debt | |
N/A | N/A | Debt | |
N/A | N/A | Seed | |
$48.0m | Early VC | ||
* | N/A | Support Program | |
Total Funding | €63.0m |
Recent News about Verdezyne
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.